FALIN ROUSE: Open Payments
NPI 1396443909 · SWEENY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 13 payments from 6 companies in 2025. Trend: 2023 $159 · 2024 $227 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $179 |
| ABBVIE INC. | 2 | $59 |
| Boston Scientific Corporation | 1 | $29 |
| Amgen Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $15 |
Products named: AIRSUPRA, QULIPTA, WATCHMAN FLX, OTEZLA, ZORYVE.
Industry payments across TX — which companies pay providers there.
